In The News Posted March 21, 2019 Share Posted March 21, 2019 ORANGEBURG, New York, March 21, 2019 /PRNewswire/ -- Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering CCM™ therapy, announced today that it has received approval from the United States Food and Drug Administration for its first-in-class Optimizer Smart ... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.